Increase in transaminase levels during COVID-19 infection and its association with poor prognosis
Singapore Med J
.
2023 Oct;64(10):640-644.
doi: 10.4103/singaporemedj.SMJ-2021-111.
Authors
Oguz Kagan Bakkaloglu
1
,
Ugur Onal
1
,
Tugce Eskazan
1
,
Enes Ali Kurt
1
,
Selcuk Candan
1
,
Ridvan Karaali
2
,
Sermin Borekci
3
,
Seval Urkmez
4
,
Yalim Dikmen
4
,
Fehmi Tabak
2
,
Murat Tuncer
1
,
Ibrahim Hatemi
1
Affiliations
1
Section of Gastroenterology, Department of Internal Medicine, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
2
Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
3
Department of Chest Diseases, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
4
Department of Anesthesiology and Intensive Care, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
PMID:
37861645
PMCID:
PMC10645006
DOI:
10.4103/singaporemedj.SMJ-2021-111
No abstract available
MeSH terms
Alanine Transaminase
Aspartate Aminotransferases
COVID-19*
Humans
Prognosis
Substances
Alanine Transaminase
Aspartate Aminotransferases